Inventor · disambiguated record
Hanmei Xu
Also filed as: XU HANMEI
11 granted patents·11 pending applications·0 citations·filing 2008–2022
78Inventor score
Files withNANJING ANJI BIOLOGICAL TECH CO LTD11XU HANMEI6JIANGSU RONGTAI BIOTECH CO LTD2HANMEI XU1NANJING ANJI BIOTECHNOLOGY CO LTD1
Top patents by PatentIndex Score
22 records- 0157US12404301B2Polypeptide having anti-aging activity, and application thereofNANJING ANJI BIOLOGICAL TECH CO LTD·Filed 2021·Granted Sep 2, 2025·0 cites·5 claims
- 0256US12286461B2Recombinant fused polypeptide and use thereofNANJING ANJI BIOLOGICAL TECH CO LTD·Filed 2020·Granted Apr 29, 2025·0 cites·9 claims
- 0356US2024247079A1Anti-hmmw antibody, composition comprising same, and nucleic acid molecule encoding same, and use thereofNANJING ANJI BIOLOGICAL TECH CO LTD·Filed 2022·Application pending·0 cites
- 0451US11407811B2Fusion protein, preparation method therefor and use thereofJIANGSU RONGTAI BIOTECH CO LTD·Filed 2018·Granted Aug 9, 2022·0 cites·8 claims
- 0549US12404303B2Polypeptide and use thereofNANJING ANJI BIOLOGICAL TECH CO LTD·Filed 2020·Granted Sep 2, 2025·0 cites·5 claims
- 0649US12398196B2Fused polypeptide with multifunctional activities and use thereofNANJING ANJI BIOLOGICAL TECH CO LTD·Filed 2020·Granted Aug 26, 2025·0 cites·7 claims
- 0748US2024076313A1Polypeptides rv3 and rv4 having anti-aging function and applications thereofNANJING ANJI BIOLOGICAL TECH CO LTD·Filed 2021·Application pending·0 cites
- 0847US2022202912A1Polypeptides in Preparation of Drugs for Treatment or Prevention of Rheumatoid ArthritisXU HANMEI·Filed 2021·Application pending·0 cites
- 0946US11192921B2Polypeptide having analgesic activity and use thereofNANJING ANJI BIOLOGICAL TECH CO LTD·Filed 2018·Granted Dec 7, 2021·0 cites·5 claims
- 1046US2022332763A1Fused polypeptide and use thereofNANJING ANJI BIOLOGICAL TECH CO LTD·Filed 2020·Application pending·0 cites
- 1142US10869931B2Polyethylene glycol-modified angiogenesis inhibitor HM-1 and application thereofNANJING ANJI BIOLOGICAL TECH CO LTD·Filed 2017·Granted Dec 22, 2020·0 cites·6 claims
- 1241US11542311B2Fusion protein, preparation method therefor and application thereof in preparing ophthalmic disease treatment, anti-inflammation and anti-tumor medicamentJIANGSU RONGTAI BIOTECH CO LTD·Filed 2018·Granted Jan 3, 2023·0 cites·5 claims
- 1340US11932872B2Dual chimeric antigen receptor-t cell which can be regulated, construction method therefor and use thereofNANJING ANJI BIOLOGICAL TECH CO LTD·Filed 2018·Granted Mar 19, 2024·0 cites·3 claims
- 1440US2022387617A1Use of cd200 protein and cd200 fusion protein in preparing a drug for treating psoriasisUNIV CHINA PHARMA·Filed 2020·Application pending·0 cites
- 1540US2010305303A1Inhibiting agent for inhibition of angiogenesis, a method for preparing the agent, a method for modifying the agent and its use for manufacturing a medicament for treating tumorXU HANMEI·Filed 2008·Application pending·0 cites
- 1636US2019031717A1Multi-functional fusion polypeptide, preparation method thereof, and application of sameNANJING ANJI BIOLOGICAL TECH CO LTD·Filed 2017·Application pending·0 cites
- 1735US2022299516A1Tumor marker aquaporin 2 protein and application thereofNANJING ANJI BIOTECHNOLOGY CO LTD·Filed 2020·Application pending·0 cites
- 1834US9458203B2Integrin-blocking polypeptides and uses thereofXU HANMEI·Filed 2012·Granted Oct 4, 2016·0 cites·6 claims
- 1934US2014329759A1Polyethylene glycol-modified integrin blocker hm-3 and use thereofXU HANMEI·Filed 2012·Application pending·0 cites
- 2032US2017100489A1Polyethylene glycol-modified integrin blocker hm-3 and use thereofHANMEI XU·Filed 2016·Application pending·0 cites
- 2130US2014378384A1Polypeptides in preparation of drugs for treatment or prevention of rheumatoid arthritisXU HANMEI·Filed 2012·Application pending·0 cites
- 2229US9879052B2Integrin-blocking polypeptides and uses thereofXU HANMEI·Filed 2016·Granted Jan 30, 2018·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Hanmei Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →